Submission for OMB Review; 30-Day Comment Request: Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH-Funded Research

Federal Register, Volume 78 Issue 82 (Monday, April 29, 2013)

Federal Register Volume 78, Number 82 (Monday, April 29, 2013)

Notices

Pages 25091-25092

From the Federal Register Online via the Government Printing Office www.gpo.gov

FR Doc No: 2013-10042

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Submission for OMB Review; 30-Day Comment Request: Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH-Funded Research

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection instrument listed below. This proposed information collection was previously published in the Federal Register on February 28, 2013, pages 13688-13689, and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov; or by fax to 202-395-6974, Attention: NIH Desk Officer.

Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Dr. Ellen Gadbois, Office of Science Policy, Office of the Director, NIH, Building 1, Room 218, MSC 0166, 1 Center Drive, Bethesda, MD 20892; or call the non-toll-free number 301-496-1454; or email your request, including your address, to gadboisel@od.nih.gov. Formal requests for additional plans and instruments must be requested in writing.

Proposed Collection: Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH-Funded Research, 0925-0601, Expiration Date 04/30/2013--EXTENSION, Office of Extramural Research, National Institutes of Health (NIH).

Need and Use of Information Collection: The form is used by applicants to request that human embryonic stem cell lines be approved for use in NIH-funded research. Applicants may submit applications at any time.

OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours is 2,550.

Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------

Number of Average time

Type of respondent Number of responses per per response Total annual

respondents respondent (in hours) burden hour

----------------------------------------------------------------------------------------------------------------

NIH grantees and others in possession of hESC 50 3 17 2,550

lines..........................................

----------------------------------------------------------------------------------------------------------------

Page 25092

Dated: April 22, 2013.

Lawrence A. Tabak,

Deputy Director, National Institutes of Health.

FR Doc. 2013-10042 Filed 4-26-13; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT